Boston—The efficacy of sugammadex (Bridion, Merck) in reversing rocuronium-induced neuromuscular blockade does not differ by the level of obesity in patients.
Claire Spradling, BS, a fourth-year medical student at the University of Missouri School of Medicine, in Columbia, presented this research at Anesthesiology 2017 (abstract A1030). The prospective cohort study included 107 patients undergoing laparoscopic bariatric surgery. The patients were randomly assigned to moderate or deep
MARCH 2, 2018